Search results for: Simon Brassel
Filter search results
Simon Brassel
4 March 2019
Simon Brassel is a Health Economist and Electrical Engineer with over ten years of professional experience in international healthcare markets. His expertise covers the whole spectrum of health technologies, from…
The Broader Value of Existing Vaccines in the Fight Against COVID-19: Beware of Tunnel Vision
8 October 2020
…they need to be. The time for multi-stakeholder action to recognise and reward the broader value of vaccines and other healthcare interventions is now (Brassel et al. 2020a; Brassel et al.,…
OHE at ISPOR Europe 2023
13 November 2023, 12:00am
…Simon Brassel Poster Session Time: 15:30 – 18:30 Discussion Period: 16:00 – 17:00 Poster Session Issues Regarding Pricing and Access to Gene and Advanced Therapy Medicinal Products Lotte Steuten (panelist)…
The WHO Technical Report on the Pricing of Cancer Medicines: Missing a Central Role for Value Assessment
8 April 2019
…key to efficient pricing and use of cancer medicines. The Research Paper outlines some for addressing these shortcomings. A new OHE Research Paper by Simon Brassel, Olga Rozanova, and Adrian…
Turning around the NHS: Reflections on the 2025 OHE Annual Lecture
14 October 2025
…Editor in the Guardian. Simon Brassel, a Senior Principal Economist at OHE wrote in response to the rise in measles cases in the UK, proposing that we need to expand where…
Breaking the European Deadlock: Part 3 – Revenue Guarantee and Subscription Models for New Antibiotics
16 January 2024
…appropriate for estimating the required magnitude of the global pull incentive (Brassel et al., 2023). The estimates are based on a review of cost and success estimates for antibiotics and are…
Are Discount Rates Used in UK Vaccine Economic Evaluations Jeopardising Investment in Immunisation Programmes?
4 August 2020
…on investment (ROI) per £1 spent on various vaccination programmes from the perspective of the UK government (Brassel and Steuten, 2020). The results show that vaccine programmes generally provide positive…
Biosimilars’ Price Dynamic in Europe
30 June 2010
…with biosimilars. Source: Simon Kucher and Partners (click graphic to enlarge) Dr Matthias Liefner is a Director in the Life Sciences Division at Simon Kucher and Partners. Publication now…
Socio-Economic Value of Adult Immunisation Programmes
18 April 2024
…Bell, E., Neri, M., Brassel, S., Chowdhury, S., & Steuten, L. (2024). A Structured Narrative Literature Review of the Broader Value of Adult Immunisation Programmes. Vaccines, 12(8), 852. https://doi.org/10.3390/vaccines12080852 For the results of…